Healthpeak Properties Zukünftiges Wachstum

Future Kriterienprüfungen 1/6

Healthpeak Properties wird ein jährliches Gewinn- und Umsatzwachstum von 6.1% bzw. 7.9% prognostiziert. Der Gewinn pro Aktie wird voraussichtlich wachsen um 8% pro Jahr. Die Eigenkapitalrendite wird in 3 Jahren voraussichtlich 4% betragen.

Wichtige Informationen

3.2%

Wachstumsrate der Gewinne

5.4%

EPS-Wachstumsrate

Health Care REITs Gewinnwachstum	31.1%
Wachstumsrate der Einnahmen	6.9%
Zukünftige Eigenkapitalrendite	3.1%
Analystenabdeckung	Good
Zuletzt aktualisiert	28 Sep 2024

Jüngste Aktualisierungen zum künftigen Wachstum

Recent updates

HealthPeak Properties: A Quality Healthcare REIT That Should Get Back To Dividend Growth

Apr 12

Healthpeak Properties: Undervalued With Strong Fundamentals

Feb 22

Healthpeak Opportunistically Cheap As Supply Moderates

Dec 13

Healthpeak Properties: 7.2% Yielding SWAN

Oct 29

Healthpeak Properties: A Safe 6.9% Yield

Oct 17

Healthpeak Is Both Undervalued And Undercovered - And A 'Buy'

Aug 10

Healthpeak Properties: 6% Yield, Profit From Market Absurdity

Jul 06

Healthpeak Properties FFO of $0.44 beats by $0.01, revenue of $524.47M beats by $5.62M

Feb 07

Healthpeak Properties declares $0.30 dividend

Feb 01

Healthpeak prices $400M notes offering

Jan 09

Healthpeak Properties Q3 2022 Earnings Preview

Oct 31

Healthpeak Properties: A Smart Income Stock Flying Under The Radar

Sep 19

Healthpeak Properties: There Are Still Better Prospects Right Now

Jul 06

Healthpeak Properties, Inc.: Steady Dividend, Poor Price Growth, High Price Multiples

Apr 21

Healthpeak Properties: Too Lofty Still

Feb 13

Gewinn- und Umsatzwachstumsprognosen

NYSE:DOC - Zukünftige Analystenschätzungen und Finanzdaten der Vergangenheit (USD Millions)
Datum	Umsatz	Gewinne	Freier Cashflow	Bargeld aus operativen Tätigkeiten	Durchschn. Anz. Analysten
12/31/2026	2,946	224	604	1,509	6
12/31/2025	2,837	284	657	1,430	11
12/31/2024	2,669	251	793	1,410	9
6/30/2024	2,412	287	953	953	N/A
3/31/2024	2,262	193	935	935	N/A
12/31/2023	2,181	304	956	956	N/A
9/30/2023	2,152	239	932	932	N/A
6/30/2023	2,116	530	922	922	N/A
3/31/2023	2,088	543	880	880	N/A
12/31/2022	2,061	495	900	900	N/A
9/30/2022	2,020	514	917	917	N/A
6/30/2022	1,981	213	885	885	N/A
3/31/2022	1,939	312	867	867	N/A
12/31/2021	1,896	117	795	795	N/A
9/30/2021	1,845	68	790	790	N/A
6/30/2021	1,787	-17	798	798	N/A
3/31/2021	1,719	-125	786	786	N/A
12/31/2020	1,645	144	758	758	N/A
9/30/2020	988	326	757	757	N/A
6/30/2020	1,102	311	785	785	N/A
3/31/2020	1,185	240	783	783	N/A
12/31/2019	1,240	159	846	846	N/A
9/30/2019	1,908	831	844	844	N/A
6/30/2019	1,826	976	790	790	N/A
3/31/2019	1,804	1,080	811	811	N/A
12/31/2018	1,191	822	849	849	N/A
9/30/2018	1,848	169	842	842	N/A
6/30/2018	1,846	62	855	855	N/A
3/31/2018	1,835	-8	N/A	850	N/A
12/31/2017	1,848	413	N/A	847	N/A
9/30/2017	1,945	549	N/A	853	N/A
6/30/2017	2,022	599	N/A	979	N/A
3/31/2017	2,101	774	N/A	1,139	N/A
12/31/2016	2,129	361	N/A	1,214	N/A
9/30/2016	1,655	384	N/A	1,353	N/A
6/30/2016	1,781	456	N/A	1,295	N/A
3/31/2016	1,850	427	N/A	1,261	N/A
12/31/2015	1,940	139	N/A	1,216	N/A
9/30/2015	2,478	235	N/A	1,233	N/A
6/30/2015	2,418	367	N/A	1,235	N/A
3/31/2015	2,347	421	N/A	1,232	N/A
12/31/2014	1,637	255	N/A	1,249	N/A
9/30/2014	2,193	927	N/A	1,188	N/A
6/30/2014	2,143	903	N/A	1,185	N/A
3/31/2014	2,119	895	N/A	1,182	N/A
12/31/2013	2,100	895	N/A	1,149	N/A

Analystenprognosen zum zukünftigen Wachstum

Einkommen vs. Sparrate: DOCDas prognostizierte Gewinnwachstum (10.4% pro Jahr) liegt über der Sparquote (2.4%).

Ertrag vs. Markt: DOCDie Erträge des Unternehmens (8.7% pro Jahr) werden voraussichtlich langsamer wachsen als der Markt US (14.9% pro Jahr).

Hohe Wachstumserträge: DOCDie Erträge des Unternehmens werden voraussichtlich steigen, jedoch nicht deutlich.

Einnahmen vs. Markt: DOCDie Einnahmen des Unternehmens (7.9% pro Jahr) werden voraussichtlich langsamer wachsen als der Markt US (8.6% pro Jahr).

Hohe Wachstumseinnahmen: DOCDie Einnahmen des Unternehmens (9.8% pro Jahr) werden voraussichtlich langsamer wachsen als 20% pro Jahr.

Wachstumsprognosen für den Gewinn je Aktie

Künftige Eigenkapitalrendite

Künftige Eigenkapitalrendite: DOCDie Eigenkapitalrendite des Unternehmens wird in 3 Jahren voraussichtlich niedrig sein (4%).

Healthpeak Properties Zukünftiges Wachstum

Future Kriterienprüfungen 1/6

Wichtige Informationen

Jüngste Aktualisierungen zum künftigen Wachstum

Healthpeak Properties, Inc. Updates Earnings Guidance for the Year 2024

Consensus EPS estimates fall by 11%, revenue upgraded

Healthpeak Properties, Inc. Provides Earnings Guidance for the Full Year 2024

Healthpeak Properties, Inc. Revises Earnings Guidance for the Year 2023

Consensus EPS estimates increase by 14%

Healthpeak Properties, Inc. Provides Earnings Guidance for the Full Year 2023

Recent updates

Healthpeak Properties, Inc. to Report Q3, 2024 Results on Oct 24, 2024

Second quarter dividend of US$0.30 announced

Second quarter 2024 earnings: EPS and revenues exceed analyst expectations

Healthpeak Properties, Inc. Declares Quarterly Cash Dividend on Common Stock, Payable on August 16, 2024

Healthpeak: Missing The Boat Above $20/Share

Healthpeak Properties: A 6.1% Yielding Healthcare Trust With Upside

Healthpeak Properties, Inc. to Report Q2, 2024 Results on Jul 25, 2024

Healthpeak Q1 - The "Best" In The Space With A 15% Upside

First quarter dividend of US$0.30 announced

Healthpeak Properties, Inc. Declares Quarterly Cash Dividend on Common Stock, Payable on May 17, 2024

First quarter 2024 earnings: EPS misses analyst expectations

Healthpeak Properties, Inc. Updates Earnings Guidance for the Year 2024

HealthPeak Properties: A Quality Healthcare REIT That Should Get Back To Dividend Growth

Healthpeak Properties, Inc. to Report Q1, 2024 Results on Apr 25, 2024

New major risk - Revenue and earnings growth

New minor risk - Shareholder dilution

Healthpeak Properties, Inc., Annual General Meeting, Apr 25, 2024

Consensus EPS estimates fall by 11%, revenue upgraded

Healthpeak Properties, Inc. (NYSE:PEAK) completed the acquisition of Physicians Realty Trust (NYSE:DOC) from BlackRock, Inc. (NYSE:BLK), The Vanguard Group, Inc., State Street Corporation (NYSE:STT) and others.

Healthpeak Properties: Undervalued With Strong Fundamentals

Healthpeak Properties, Inc. has filed a Follow-on Equity Offering.

Full year 2023 earnings: EPS exceeds analyst expectations

Healthpeak Properties, Inc. Provides Earnings Guidance for the Full Year 2024

Upcoming dividend of US$0.30 per share at 6.7% yield

Third quarter dividend of US$0.30 announced

Healthpeak Properties, Inc. to Report Q4, 2023 Results on Feb 08, 2024

New major risk - Revenue and earnings growth

Healthpeak Properties, Inc. Declares Quarterly Cash Dividend, Payable on February 26, 2024

Healthpeak Opportunistically Cheap As Supply Moderates

Healthpeak Properties, Inc. (NYSE:PEAK) entered into a definitive agreement to acquire Physicians Realty Trust (NYSE:DOC) for approximately $2.7 billion in a merger of equals transaction.

Healthpeak Properties: 7.2% Yielding SWAN

Healthpeak Properties, Inc. to Report Q3, 2023 Results on Oct 30, 2023

Healthpeak Properties: A Safe 6.9% Yield

Healthpeak Is Both Undervalued And Undercovered - And A 'Buy'

Second quarter 2023 earnings: EPS misses analyst expectations

Healthpeak Properties, Inc. Revises Earnings Guidance for the Year 2023

Healthpeak Properties: 6% Yield, Profit From Market Absurdity

Healthpeak Properties, Inc. to Report Q2, 2023 Results on Jul 27, 2023

Consensus EPS estimates increase by 14%

First quarter 2023 earnings: EPS exceeds analyst expectations

Independent Director recently bought US$86k worth of stock

High number of new directors

Now 24% undervalued after recent price drop

CEO, President & Director recently bought US$385k worth of stock

Full year 2022 earnings: EPS misses analyst expectations

Healthpeak Properties, Inc. Provides Earnings Guidance for the Full Year 2023

Healthpeak Properties FFO of $0.44 beats by $0.01, revenue of $524.47M beats by $5.62M

Healthpeak Properties, Inc. Declares Quarterly Cash Dividend, Payable on February 23, 2023

Healthpeak Properties declares $0.30 dividend

Healthpeak Properties, Inc. to Report Q4, 2022 Results on Feb 07, 2023

Consensus forecasts updated

Healthpeak prices $400M notes offering

Healthpeak Properties, Inc. Revises Earnings Guidance for the Year 2022

Third quarter 2022 earnings: EPS exceeds analyst expectations

Healthpeak Properties, Inc. Revises Earnings Guidance for the Year 2022

Healthpeak Properties Q3 2022 Earnings Preview

Healthpeak Properties, Inc. Declares Quarterly Cash Dividend, Payable on November 18, 2022

High number of new directors

Healthpeak Properties Announces Management Changes

Healthpeak Properties, Inc. to Report Q3, 2022 Results on Nov 01, 2022

Healthpeak Properties: A Smart Income Stock Flying Under The Radar

Healthpeak Properties, Inc. (NYSE:PEAK) announces an Equity Buyback for $500 million worth of its shares.

Second quarter 2022 earnings: EPS and revenues exceed analyst expectations

Healthpeak Properties, Inc. (NYSE:PEAK) announces an Equity Buyback for $500 million worth of its shares.

Healthpeak Properties, Inc. Revises Earnings Guidance for the Year 2022

Healthpeak Properties Declares Quarterly Cash Dividend on Common Stock, Payable on August 19, 2022

Healthpeak Properties, Inc. to Report Q2, 2022 Results on Aug 02, 2022

Healthpeak Properties, Inc. Announces the Resignation of Lydia H. Kennard from the Board of Directors

Healthpeak Properties: There Are Still Better Prospects Right Now